Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
Abstract Background Circulating tumor cells (CTCs) has been demonstrated as a promising liquid biopsy marker for breast cancer (BC). However, the intra-patient heterogeneity of CTCs remains a challenge to clinical application. We aim at profiling aggressive CTCs subpopulation in BC utilizing the dis...
Main Authors: | Jing Chen, Changsheng Ye, Jianyu Dong, Shunwang Cao, Yanwei Hu, Bo Situ, Xiaoxue Xi, Sihua Qin, Jiasen Xu, Zhen Cai, Lei Zheng, Qian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-020-02237-8 |
Similar Items
-
Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
by: Jing Chen, et al.
Published: (2022-11-01) -
Tryptophan Metabolites as Biomarkers for Esophageal Cancer Susceptibility, Metastasis, and Prognosis
by: Yun Chen, et al.
Published: (2022-02-01) -
Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
by: Katiusse Alves dos Santos, et al.
Published: (2020-12-01) -
The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer
by: Yamei Zhao, et al.
Published: (2022-07-01) -
Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
by: Yilin Li, et al.
Published: (2023-08-01)